ICAD
ICAD Inc
Price:  
3.87 
USD
Volume:  
190,074.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD EV/EBITDA

-101.3%
Upside

As of 2026-01-05, the EV/EBITDA ratio of ICAD Inc (ICAD) is -17.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICAD's latest enterprise value is 86.28 mil USD. ICAD's TTM EBITDA according to its financial statements is -4.98 mil USD. Dividing these 2 quantities gives us the above ICAD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 3.0x - 6.2x 4.3x
Forward P/E multiples 3.0x - 7.2x 4.3x
Fair Price 0.19 - (0.39) (0.05)
Upside -95.0% - -110.0% -101.3%
3.87 USD
Stock Price
(0.05) USD
Fair Price

ICAD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA